Abstract
Background
Early recurrence (ER) within a 90-day blanking period (BP) in catheter ablation (CA) for atrial fibrillation (AF) is a risk factor for late recurrence (LR) after 90 days postoperatively. However, few reports have examined them in the second CA and compared them to the first CA. Moreover, in recent years, there have been reports suggesting that BP should be reduced from 90 to 30 days. Therefore, the association between ER and LR in the first and the second CA was examined, and the validity of a 30-day BP was evaluated.
Methods
A total of 511 consecutive patients undergoing the first CA and 116 of these patients undergoing the second CA for AF at a single institution from November 2016 to December 2020 were analyzed retrospectively.
Results
When ER within a 90-day BP was divided into 0–30 days and 31–90 days according to the timing of the last ER episode, the hazard ratios on LR of them relative to no ER were 2.7 {95% confidence interval (CI) 1.7–4.2} and 9.7 (95% CI 6.6–14.3), respectively, for the first CA and 15.3 (95% CI 4.7–50.1) and 44.1 (95% CI 14.0–139.4), respectively, for the second CA.
Conclusions
ER was strongly associated with LR, especially in patients with the last episode of ER more than 30 days after CA. This was pronounced in cases after the second CA, when PVI appeared to be completed. With the current improvement in PVI durability, BP may be acceptable for 30 days.
Graphical Abstract
Similar content being viewed by others
Data Availability
The data that support the findings of this study are available from the corresponding author, [KK], upon reasonable request.
References
Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, … Mitamura H. JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. J Arrhythmia. 2021;37(4):709–870. https://doi.org/10.1002/joa3.12491.
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, … Willems S. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2018;20(1):e1–e160. https://doi.org/10.1093/europace/eux274.
Gottlieb LA, Dekker LRC, Coronel R. The blinding period following ablation therapy for atrial fibrillation: proarrhythmic and antiarrhythmic pathophysiological mechanisms. JACC: Clinical Electrophysiology. Elsevier Inc; 2021. https://doi.org/10.1016/j.jacep.2021.01.011.
Popa MA, Kottmaier M, Risse E, Telishevska M, Lengauer S, Wimbauer K, …, Bourier F. Early arrhythmia recurrence after catheter ablation for persistent atrial fibrillation: is it predictive for late recurrence?. Clin Res Cardiol. 2022;111(1):85–95. https://doi.org/10.1007/s00392-021-01934-8.
Onishi N, Kaitani K, Nakagawa Y, Inoue K, Kobori A, Nakazawa Y, …, Shizuta S. The association between late-phase early recurrence within the blanking period after atrial fibrillation catheter ablation and long-term recurrence: insights from a large-scale multicenter study. Int J Cardiol. 2021;341(June):39–45. https://doi.org/10.1016/j.ijcard.2021.07.053.
Stabile G, Iacopino S, Verlato R, Arena G, Pieragnoli P, Molon G, …, Tondo C. Predictive role of early recurrence of atrial fibrillation after cryoballoon ablation. Europace. 2020;22(12):1798–1804. https://doi.org/10.1093/europace/euaa239.
Willems S, Khairy P, Andrade JG, Hoffmann BA, Levesque S, Verma A,…, MacLe L. Redefining the blanking period after catheter ablation for paroxysmal atrial fibrillation: insights from the ADVICE (adenosine following pulmonary vein isolation to target dormant conduction elimination) trial. Circulation: Arrhythmia Electrophysiol. 2016;9(8). https://doi.org/10.1161/CIRCEP.115.003909.
Xia Y, Liu J, Jia Y, Zhang H, Yu M, Li X, Fang P. Redefining the blanking period by a long-term follow-up after atrial fibrillation ablation using second-generation cryoballoon. Int Heart J. 2020;61(5):936–43. https://doi.org/10.1536/ihj.20-234.
Saglietto A, Ballatore A, Xhakupi H, Rubat Baleuri F, Magnano M, Gaita F, …, Anselmino M. Evidence-based insights on ideal blanking period duration following atrial fibrillation catheter ablation. Eur : Eur Pacing, Arrhythmias Cardiac Electrophysiolo: J Work Groups Cardiac Pacing Arrhythmias Cardiac Cell Electrophysiol Eur Soc Cardiol. 2022 24(12):1899–1908. https://doi.org/10.1093/europace/euac098.
Schiavone M, Gasperetti A, Martignani C, Montemerlo E, Ciconte G, Ziacchi M, …, Forleo GB. Atrial fibrillation recurrences during the blanking period after catheter ablation with the laser balloon technique. J Cardiovasc Electrophysiol. 2023. https://doi.org/10.1111/jce.16087.
Darden D, Aldaas O, Malladi CL, Mylavarapu PS, Munir MB, Han FT, …, Hsu JC. Association between early recurrences of atrial tachyarrhythmias and long-term outcomes in patients after repeat atrial fibrillation ablation. J Intervent Cardiac Electrophysiol. 2022;64(2):323–331. https://doi.org/10.1007/s10840-021-00987-z.
Hirokami J, Hiroshima K, Nagashima M, Fukunaga M, Korai K, Ando K. A novel ablation strategy for refractory atrial fibrillation based on the fractionated signal area in the atrial muscle. HeartRhythm Case Reports. 2021;7(12):844–8. https://doi.org/10.1016/j.hrcr.2021.09.010.
Mujović N, Marinković M, Lenarczyk R, Tilz R, Potpara TS. August 1). Catheter ablation of atrial fibrillation: an overview for clinicians. Adv Ther. 2017;34:1897–917. https://doi.org/10.1007/s12325-017-0590-z.
Tanaka N, Inoue K, Kobori A, Kaitani K, Morimoto T, Kurotobi T, …, Shizuta S. Sex differences in atrial fibrillation ablation outcomes: insights from a large-scale multicentre registry. EP Europace. 2020:1–13. https://doi.org/10.1093/europace/euaa104.
de Heide J, Kock-Cordeiro DBM, Bhagwandien RE, Hoogendijk MG, van der Meer KC, Wijchers SA, …, Yap SC. Impact of undiagnosed obstructive sleep apnea on atrial fibrillation recurrence following catheter ablation (OSA-AF study). IJC Heart and Vasculature. 2022;40. https://doi.org/10.1016/j.ijcha.2022.101014.
Tilz RR, Rillig A, Thum AM, Arya A, Wohlmuth P, Metzner A, …, Ouyang F. Catheter ablation of long-standing persistent atrial fibrillation: 5-year outcomes of the Hamburg sequential ablation strategy. J Am Coll Cardiol. 2012;60(19):1921–1929. https://doi.org/10.1016/j.jacc.2012.04.060.
Guckel D, Isgandarova K, Bergau L, Piran M, El Hamriti M, Imnadze G, …, Sohns C. The effect of diabetes mellitus on the recurrence of atrial fibrillation after ablation. J Clin Med. 2021;10(21). https://doi.org/10.3390/jcm10214863.
Chung I, Khan Y, Warrens H, Seshasai RK, Sohal M, Banerjee D. Catheter ablation for atrial fibrillation in patients with chronic kidney disease and on dialysis: a meta-analysis and review. CardioRenal Medicine. 2022;12(4):155–72. https://doi.org/10.1159/000525388.
Kanda Y. Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant. 2013;48(3):452–8. https://doi.org/10.1038/bmt.2012.244.
Oral H, Knight BP, Tada H, Chugh A, Hassan S, Scharf C, …, Ann Arbor F. Clinical significance of early recurrences of atrial fibrillation after pulmonary vein isolation. 2002.
Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJG, …, Shemin RJ. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Europace. 2007;9(6):335–379. https://doi.org/10.1093/europace/eum120.
Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, …, Vardas PE. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. In Europace. 2012 (Vol. 14, pp. 528–606). https://doi.org/10.1093/europace/eus027.
Sørensen SK, Johannessen A, Worck R, Hansen ML, Hansen J. Radiofrequency versus cryoballoon catheter ablation for paroxysmal atrial fibrillation: durability of pulmonary vein isolation and effect on atrial fibrillation burden: the RACE-AF randomized controlled trial. Circulation: Arrhythmia Electrophysiol. 2021;14(5), E009573. https://doi.org/10.1161/CIRCEP.120.009573.
Funding
None.
Author information
Authors and Affiliations
Contributions
NOn wrote the manuscript, and KK critically revised it. AS, AY, TK, SK, MO, NH, FN, NOy, and TJ critically read and commented on the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests. The study protocol was approved on May 10, 2023, by a suitably constituted Ethics Committee of Japanese Red Cross Otsu Hospital (no. 778), and it conforms to the provisions of the Declaration of Helsinki.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Onishi, N., Suenaga, A., Yoshida, A. et al. Rethinking appropriate blanking period after atrial fibrillation ablation. J Interv Card Electrophysiol (2024). https://doi.org/10.1007/s10840-024-01754-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10840-024-01754-6